PharmaShots | Incisive News in 3 Shots

Subscribe Now

Recieves

GSK's Benlysta (belimumab) Receives the US FDA's Approval as the First Therapy for Active Lupus Nephritis (LN)

GSK's Benlysta (belimumab) Receives the US FDA's Approval as the First Therapy for Active Lupus Nephritis (LN)

December 18, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us